Regular monitoring of renal function, HbA1c, and body weight is recommended, with treatment adjustments made according to clinical response and tolerability
Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA, et al
Binders (Ultra Binder) to capture toxins
Depending on the patients needs, treatment plans may also include: Hormonal therapies or bioidentical hormones, when indicated Lifestyle and metabolic health optimization Weight management strategies, including medications such as semaglutide or tirzepatide, when appropriate Ongoing education and follow-up through a dedicated support team This integrated approach allows clinicians to address hormonal decline, nervous system signaling, and overall sexual wellness together
This decline can be exacerbated by factors such as poor nutrition, environmental toxins, and chronic stress
Patients report a reduction in post-workout soreness duration, some initial visible changes in muscle fullness from improved glycogen storage, and the beginning of body fat reduction around the abdomen where GH-driven lipolysis preferentially acts on visceral fat stores
